CA2015475A1 - Agent pour le traitement de l'osteoarthrite - Google Patents

Agent pour le traitement de l'osteoarthrite

Info

Publication number
CA2015475A1
CA2015475A1 CA2015475A CA2015475A CA2015475A1 CA 2015475 A1 CA2015475 A1 CA 2015475A1 CA 2015475 A CA2015475 A CA 2015475A CA 2015475 A CA2015475 A CA 2015475A CA 2015475 A1 CA2015475 A1 CA 2015475A1
Authority
CA
Canada
Prior art keywords
osteoarthritis
group
treating agent
pharmaceutical composition
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2015475A
Other languages
English (en)
Other versions
CA2015475C (fr
Inventor
Fumihiko Kimura
Yutaka Mukaida
Koju Watanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kureha Corp
Original Assignee
Kureha Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kureha Corp filed Critical Kureha Corp
Publication of CA2015475A1 publication Critical patent/CA2015475A1/fr
Application granted granted Critical
Publication of CA2015475C publication Critical patent/CA2015475C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002015475A 1989-04-28 1990-04-26 Agent pour le traitement de l'osteoarthrite Expired - Fee Related CA2015475C (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP110148/89 1989-04-28
JP11014889 1989-04-28
JP34065/90 1990-02-15
JP2034065A JPH085780B2 (ja) 1989-04-28 1990-02-15 変形性関節症治療剤

Publications (2)

Publication Number Publication Date
CA2015475A1 true CA2015475A1 (fr) 1990-10-28
CA2015475C CA2015475C (fr) 1995-04-18

Family

ID=26372861

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002015475A Expired - Fee Related CA2015475C (fr) 1989-04-28 1990-04-26 Agent pour le traitement de l'osteoarthrite

Country Status (9)

Country Link
US (1) US4997850A (fr)
EP (1) EP0395441B1 (fr)
JP (1) JPH085780B2 (fr)
KR (1) KR920004095B1 (fr)
AU (1) AU614227B2 (fr)
CA (1) CA2015475C (fr)
DE (1) DE69016821T2 (fr)
DK (1) DK0395441T3 (fr)
ZA (1) ZA902975B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5273033A (en) * 1991-09-19 1993-12-28 Murray Electronics Associates Limited Partnership Electrical stimulation for treatment of osteoarthritis
US5388644A (en) * 1993-02-08 1995-02-14 Buckman Laboratories International, Inc. Application of N,N-dialkylamides to reduce precipitation of asphalt from crude oil
JPH0725761A (ja) * 1993-07-09 1995-01-27 Kureha Chem Ind Co Ltd 軟骨保護剤
GB9400047D0 (en) * 1994-01-04 1994-03-02 Norsk Hydro As Pharmaceutical compositions
US6025401A (en) * 1996-11-15 2000-02-15 The Picower Institute For Medical Research Method and agents for inhibiting protein aging
US8246969B2 (en) 2001-11-16 2012-08-21 Skinmedica, Inc. Compositions containing aromatic aldehydes and their use in treatments
PT1443915E (pt) * 2001-11-16 2006-11-30 Bioform Medical Inc Composições farmacêuticas e cosméticas contendo aldeídos aromáticos com grupos oxilo
US20030157154A1 (en) * 2002-01-04 2003-08-21 Bryan Fuller Compositions containing hydroxy aromatic aldehydes and their use in treatments
US20040162582A1 (en) * 2003-02-13 2004-08-19 Hmt High Medical Technologies Ag Treatment of osteoarthritis
CA2525789A1 (fr) * 2003-05-15 2004-12-02 Cutanix Corporation Compositions contenant un melange d'un agent pharmaceutique ou d'un agent cosmetique et d'un aldehyde aromatique de support de groupe oxy
EP2789342A1 (fr) 2004-06-17 2014-10-15 Thrasos Innovation, Inc. Composés liés au TDF et analogues correspondants
US8299212B2 (en) 2005-09-20 2012-10-30 Thrasos Therapeutics, Inc. TDF-related compounds and analogs thereof, analogs and bioactive fragments
ES2569660T3 (es) 2007-06-08 2016-05-12 Mannkind Corporation Inhibidores de la IRE-1alfa
US8263069B2 (en) 2008-12-31 2012-09-11 Johnson Lanny L Compositions including anthocyanin or anthocyanidin for the prevention or treatment of articular cartilage-associated conditions
WO2012094638A1 (fr) 2011-01-07 2012-07-12 Skinmedica, Inc. Compositions de modification de mélanine et procédés d'utilisation
US9498413B2 (en) 2013-05-01 2016-11-22 Lanny Leo Johnson Antimicrobials and methods of use thereof for wound healing
US10016380B2 (en) 2013-05-01 2018-07-10 Lanny Leo Johnson Antimicrobials and methods of use thereof
US10398664B2 (en) 2013-05-01 2019-09-03 Lanny Leo Johnson Methods of diagnosing and treating infected implants
US9968623B2 (en) 2013-08-29 2018-05-15 Lanny Leo Johnson Prepackaged sterile syringe or containers with various substance concentrations with or without bioactive reagent
US11980635B2 (en) 2014-11-05 2024-05-14 Lanny Leo Johnson Methods of oral administration of protocatechuic acid for treating or reducing the severity of a joint injury or disease
US11925656B2 (en) 2014-11-05 2024-03-12 Lanny Leo Johnson Biological total joint replacement
WO2018204621A1 (fr) * 2017-05-03 2018-11-08 Johnson Lanny Leo Compositions comprenant de l'acide protocatéchuique pour la prévention ou le traitement de l'ostéoarthrite

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54160740A (en) * 1978-06-09 1979-12-19 Takeda Chem Ind Ltd Anti-fibrotic agent
JPS6026370B2 (ja) * 1978-10-09 1985-06-24 寶酒造株式会社 制癌剤
JPS58183619A (ja) * 1982-04-21 1983-10-26 Itochu Shiryo Kk 家禽類の発育促進方法
JPS59196818A (ja) * 1983-04-25 1984-11-08 Kureha Chem Ind Co Ltd 腎炎治療剤
US4758591A (en) * 1983-12-26 1988-07-19 Kureha Kagaku Kogyo Kabushiki Kaisha Dialkanoyloxybenzylidene dialkanoate
YU213587A (en) * 1986-11-28 1989-06-30 Orion Yhtymae Oy Process for obtaining new pharmacologic active cateholic derivatives

Also Published As

Publication number Publication date
ZA902975B (en) 1991-01-30
AU5375690A (en) 1990-11-01
JPH085780B2 (ja) 1996-01-24
AU614227B2 (en) 1991-08-22
DE69016821T2 (de) 1995-08-17
US4997850A (en) 1991-03-05
DK0395441T3 (da) 1995-06-26
JPH0372418A (ja) 1991-03-27
EP0395441A3 (fr) 1992-03-25
DE69016821D1 (de) 1995-03-23
EP0395441B1 (fr) 1995-02-15
KR900015718A (ko) 1990-11-10
KR920004095B1 (ko) 1992-05-25
CA2015475C (fr) 1995-04-18
EP0395441A2 (fr) 1990-10-31

Similar Documents

Publication Publication Date Title
KR960700708A (ko) 3,4-디아릴크로만을 이용한 뼈 손실의 억제방법(methdos for inhibiting bone loss with 3,4-diarylchroman)
MY130157A (en) Method of use for inhibiting bone loss and lowering serum cholesterol
ATE60759T1 (de) Bisdimethoxymethyl(trimethoxybenzyl)isochinolinium salze, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen.
EP0911331A3 (fr) Dérivés substitués de dibenzoxazépine, compositions pharmaceutiques et procédés d'utilisation
HUT77627A (hu) 2,2-Diklór-alkánkarbonsavak, eljárás előállításukra és ezeket tartalmazó, inzulinrezisztencia kezelésére alkalmazható gyógyszerkészítmények
EP1108428A3 (fr) Compositions contenant l'acétate de phényle et ses dérivés et leur utilisation dans le traitement des maladies virales
PL1664041T3 (pl) Przydatne do leczenia bólu związki fenylowo-karboksyamidowe
EP0395441A3 (fr) Agent pour le traitement de l'ostéo-arthrite
CA2192555A1 (fr) Compose de 2-acylaminopropanol et composition medicinale
KR970702291A (ko) 에퀼린의 산 이성질화체로부터 제조된 에퀼린 이중결합 이성질체(Anequilin double bond isomer from the acid isomerization of equilin)
EP0173664A3 (fr) Dérivés de benzimidazole biologiquement actifs et leur procédé de préparation
PL320560A1 (en) Pharmaceutic composition
WO1993014767A3 (fr) Preparation pharmaceutique a base de rhamnolipides utilisee pour traiter les maladies dermatologiques, par exemple, les infections du virus du papillome
EP0220523A3 (fr) Composés de l'acide quinoléinecarboxylique, leur procédés de préparation, composition pharmaceutique et utilisation
EP0398720A3 (fr) Dérivés de pipérazine
UA27108A1 (uk) Аhтрацикліhові глікозиди та їх фармацевтичhо прийhятhі кислотhо-адитивhі солі, спосіб їх одержаhhя, похідhі 1,6-дийод-3-оксапеhтаhу та спосіб їх одержаhhя
RU98103388A (ru) (r)-5-бром-n-(1-этил-4-метилгексагидро-1н-1,4-диазепин-6-ил)-2-метокси-6-м етиламино-3-пиридинкарбоксамид, способ его получения и фармацевтическая композиция, содержащая указанное соединение
DK0420121T3 (da) Antitumormiddel
EP0743308A3 (fr) Composé quinazoléine et composition contre les tumeurs le contenant comme composé actif
HUT70531A (en) Arylmorpholine derivatives, pharmaceutical compositions containing them as active agent and process for preparing them
EP0743065A3 (fr) Composés du vanadium pour inhiber la perte osseuse
EP1074554A3 (fr) Dérivés de 7-acyl-3-(carbamoyloxy substitué)-céphème, leur application et leur procédé de préparation
HU903092D0 (en) Process for the preparation of buten-carboxylic acid derivatives and pharmaceutical compositions containing such compounds
HU9500175D0 (en) Pharmacologically active alpha-[tertiary-aminomethyl]-benzenemethanol derivatives
EP0129891A3 (fr) Dérivés de quinazolinone, procédés pour leur préparation et compositions pharamceutiques les comprenant

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed